Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.
In recent years, targeted agents have replaced cytokine therapy as the standard of care for patients with metastatic renal cell carcinoma. We report a patient with multiple metastases from renal cell carcinoma treated with cytoreductive surgery and pazopanib. The treatment resulted in an early and prolonged response, without toxicity.